Mupadolimab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5136
Add to Compare
$315.00 - $19,890.00

Mupadolimab Biosimilar - Research Grade

Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
≥95% monomer by analytical SEC, >95% by SDS Page
Species Reactivity
Human
Target
CD73
Concentration
5mg/ml
Isotype
Human IgG1 (N297Q/E356D/M358L)-Kappa
Host
CHO Cells
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Applications
Functional Assays
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity
Detects human CD73
Shipping Conditions
Blue ice
Background
Characteristic of Hodgkin lymphoma and anaplastic large-cell lymphoma, CD30 (TNFRSF8) is a TNF-receptor-superfamily antigen that has become a key target in haematological cancer research. This research-grade anti-human CD30 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of brentuximab, supplied for research use only (RUO). It is produced to in vivo standards with low endotoxin and is available in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Typical applications include tumour-antigen binding and internalisation assays, in vitro screening, antibody-drug conjugate development, and in vivo preclinical lymphoma models.
Uniprot
P21589
Buffer
ICH3002
Sequence
https://www.imgt.org/mAb-DB/
Write Your Own Review
You're reviewing:Mupadolimab Biosimilar - Research Grade
Your Rating
Back to Top